Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...
StockNews.com upgraded shares of Inogen (NASDAQ:INGN – Free Report) from a hold rating to a buy rating in a report released on Monday. Separately, Needham & Company LLC restated a “hold” rating on ...
Recent Development for INGN In October, INGN announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 utilizes Inogen’s patented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback